本文選題：藥品安全　切入點(diǎn)：責(zé)任保險(xiǎn)　出處：《遼寧大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：自1978年改革開放以來(lái),不僅我國(guó)的經(jīng)濟(jì)發(fā)展取得了快速的進(jìn)步,我國(guó)很多事業(yè)也取得了飛快的進(jìn)步,例如我國(guó)醫(yī)藥產(chǎn)業(yè)快速發(fā)展,雖然其市場(chǎng)化程度在不斷加深,但這一進(jìn)步對(duì)我國(guó)國(guó)民健康以及其他方面的影響是具有雙面性的。它既有有利的一面,又有不利的一面。好的一面是,正是由于醫(yī)藥行業(yè)的快速發(fā)展,改善了我國(guó)人民的生活狀況,人們的生活變的如此快捷與方便,這提高了居民幸福指數(shù)。但不好的一面是,有些心術(shù)不正的人可能利用這一科技,利用藥品來(lái)制造麻煩,藥品的安全性越來(lái)越被人們所重視。藥品安全對(duì)人們來(lái)說(shuō)是至關(guān)重要的,這關(guān)系著每個(gè)人的生命,不僅我們自身應(yīng)該予以關(guān)注,政府也應(yīng)該提高對(duì)藥品安全重視度。但是,要想真正提升藥品安全,必須提高個(gè)人的安全意識(shí),只有落實(shí)到每個(gè)主體上,才能從根本上解決問(wèn)題。這不僅要求國(guó)家應(yīng)該制定相關(guān)法律來(lái)保證實(shí)施,同時(shí),這也是我們每個(gè)公民的責(zé)任。本文以維護(hù)消費(fèi)者的根本利益為出發(fā)點(diǎn),從方方面面論述我國(guó)建立藥品安全責(zé)任保險(xiǎn)的必要性與可行性。面對(duì)頻繁發(fā)生的藥品安全責(zé)任事故事件,建立藥品安全責(zé)任制度是勢(shì)在必行的,制定的原因可以歸納為以下幾種:一是對(duì)于一些質(zhì)量不合格的藥品給消費(fèi)者帶來(lái)預(yù)期之外的不良反應(yīng)時(shí),生產(chǎn)商是否應(yīng)該承擔(dān)相應(yīng)的責(zé)任問(wèn)題,如果生產(chǎn)商的確應(yīng)該承擔(dān)責(zé)任時(shí),因藥品服用時(shí)間過(guò)長(zhǎng)已經(jīng)無(wú)法找到生產(chǎn)商,這時(shí)責(zé)任該由誰(shuí)負(fù)責(zé);二是藥品因本身固有的危險(xiǎn)性的存在,對(duì)于藥品質(zhì)量問(wèn)題的認(rèn)定是很難的,在實(shí)務(wù)中認(rèn)定藥品質(zhì)量合格與否的標(biāo)準(zhǔn)更難確定,在這方面的法律法規(guī)仍然很模糊;三是對(duì)于一些藥品安全導(dǎo)致的事件,我國(guó)應(yīng)該建立藥品安全責(zé)任強(qiáng)制保險(xiǎn)來(lái)避免事故發(fā)生后的糾紛問(wèn)題,但是現(xiàn)有的法律仍然沒(méi)有相關(guān)規(guī)定。本文運(yùn)用多種方法相結(jié)合來(lái)研究藥品安全責(zé)任保險(xiǎn)相關(guān)問(wèn)題,在此基礎(chǔ)上,提出對(duì)策建議以推進(jìn)藥品安全強(qiáng)制責(zé)任保險(xiǎn)的推出。
[Abstract]:Since the reform and opening up in 1978, not only has China made rapid progress in economic development, but also many undertakings in China have made rapid progress, such as the rapid development of the pharmaceutical industry in our country, although the degree of marketization is deepening. But this progress has a dual impact on our national health and other aspects. It has both advantages and disadvantages. The good side is that it is precisely because of the rapid development of the pharmaceutical industry, It has improved the living conditions of our people, and people's lives have become so fast and convenient, which has increased the happiness index of the residents. But the bad side is that some people with bad intentions may take advantage of this technology and use drugs to create trouble. People pay more and more attention to the safety of drugs. Drug safety is very important to people, which is related to the lives of everyone. Not only should we pay attention to it, but the government should also pay more attention to the safety of drugs. However, In order to really enhance drug safety, we must raise the personal safety awareness. Only by implementing it to each subject can we solve the problem fundamentally. This not only requires the state to formulate relevant laws to ensure implementation, but also, at the same time, This is also the responsibility of each of our citizens. This paper, based on the fundamental interests of consumers, discusses the necessity and feasibility of establishing drug safety liability insurance in China from all aspects. In the face of frequent incidents of drug safety liability accidents, It is imperative to establish a drug safety liability system. The reasons for the establishment can be summarized as follows: first, when some unqualified drugs bring unexpected adverse reactions to consumers, Whether the manufacturer should bear the corresponding responsibility, if the manufacturer should take the responsibility, the manufacturer can not find the manufacturer because the drug is used for too long, then who should be responsible for the responsibility; Second, because of the inherent danger of drugs, it is very difficult to identify the quality of drugs, and it is more difficult to determine the standards of drug quality in practice, and the laws and regulations in this respect are still very vague; Third, for some incidents caused by drug safety, China should establish compulsory drug safety liability insurance to avoid disputes after the accident. However, there are still no relevant provisions in the existing laws. This paper uses a variety of methods to study the related issues of drug safety liability insurance, and puts forward countermeasures and suggestions to promote the introduction of compulsory liability insurance for drug safety.
【學(xué)位授予單位】：遼寧大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：F426.72;F842.6

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 吳杰;趙桂芹;;我國(guó)非壽險(xiǎn)業(yè)承保業(yè)務(wù)間的風(fēng)險(xiǎn)分散效應(yīng)研究[J];保險(xiǎn)研究;2014年12期

2 李祝用;姚兆中;;再論交強(qiáng)險(xiǎn)的制度定位——立法的缺陷、行政法規(guī)與司法解釋的矛盾及其解決[J];保險(xiǎn)研究;2014年04期

3 王云蘭;阮俊慧;;地方性法規(guī)、規(guī)章的效力分析——淺析《中華人民共和國(guó)立法法》第80條、第82條、第86條[J];經(jīng)濟(jì)研究導(dǎo)刊;2011年30期

4 胡曉;周典;吳丹;張勤;張博;;公立醫(yī)院取消藥品加成利弊分析[J];中國(guó)衛(wèi)生事業(yè)管理;2011年01期

5 褚萬(wàn)里;;我國(guó)交強(qiáng)險(xiǎn)制度的成功與不足[J];道路交通管理;2010年08期

6 周書美;;論我國(guó)藥品費(fèi)用快速增長(zhǎng)的原因與控制[J];內(nèi)蒙古財(cái)經(jīng)學(xué)院學(xué)報(bào)(綜合版);2010年02期

7 田昕;宋雅然;張新平;;以系統(tǒng)理論分析國(guó)家基本藥物制度[J];中國(guó)衛(wèi)生事業(yè)管理;2010年04期

8 鄭振Oz;;逐步解決公立醫(yī)院“以藥補(bǔ)醫(yī)”的探討[J];衛(wèi)生經(jīng)濟(jì)研究;2010年01期

9 張領(lǐng)偉;羅鳴;;論交強(qiáng)險(xiǎn)經(jīng)營(yíng)模式與道路救助基金職能[J];保險(xiǎn)研究;2009年12期

10 吳年冬;;淺談我國(guó)產(chǎn)品責(zé)任保險(xiǎn)體系的構(gòu)建[J];區(qū)域金融研究;2009年04期

，

本文編號(hào)：1565053